Aspen have recently finalised an agreement with Teva Pharmaceuticals, which is the worlds largest generic drug company, appointing Aspen Australia as Teva distributor in Australia and New Zealand, with first rights of refusal for all Teva products.

This is a real coup for Aspen as there is no shortage of companies wanting to represent Teva in this market.  This will ensure great and rapid growth for Aspen in the foreseeable future as Teva has one of the richest pipelines in the industry and we are very fortunate, and excited, to be in partnership with such an esteemed global player.

Expect to have see many new product launches, particularly in oncology and in the hospital market.